
Korro Bio, Inc.
KRROHealthcare|Biotechnology|US
$14.75
+0.02 (+0.14%)
DCF Value
$9.43
Tangible Book / Share
$4.95
Cash / Share
$5.88
Next Earnings Report
Mar 11, 2027
EPS est. -$1.29 · Revenue est. $187.5K
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest May 12, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (1)
Aug 2027
Est. completion
P1P2Urea Cycle Disorders, Inborn
Phase 1/2 Study of KRRO-121 in Healthy Volunteers and Patients With UCD
NCT07773246n=30
Recent Press Releases
Korro to Present at the 2026 Jefferies Global Healthcare Conference in London
Nov 6, 2026 · GlobeNewsWire
Korro Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Nov 5, 2026 · GlobeNewsWire
Korro Reports Best-in-Class Preclinical Data for KRRO-111 Demonstrating Potential to Benefit Lung and Liver Manifestations of Alpha-1 Antitrypsin Deficiency
Oct 22, 2026 · GlobeNewsWire
Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 16, 2026 · GlobeNewsWire
Korro Announces First Cohort Dosed in Phase 1/2 Clinical Trial (ANCHOR) for KRRO-121
Oct 5, 2026 · GlobeNewsWire
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Sep 11, 2026 · GlobeNewsWire
Korro to Participate in Upcoming Investor Conferences
Aug 27, 2026 · GlobeNewsWire
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Aug 14, 2026 · GlobeNewsWire
SEC Filings (87)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 5, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Nov 5, 2026 | 8-K | Material event | DocumentIndex |
| Oct 27, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Oct 22, 2026 | 8-K | Material event | DocumentIndex |
| Oct 5, 2026 | 8-K | Material event | DocumentIndex |
| Aug 19, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 6, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 6, 2026 | 8-K | Material event | DocumentIndex |
| Aug 4, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Jul 29, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jun 11, 2026 | 8-K | Material event | DocumentIndex |
| May 19, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 12, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| May 7, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 7, 2026 | 8-K | Material event | DocumentIndex |
| Apr 16, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 16, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 16, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 2, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Mar 27, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Mar 20, 2026 | EFFECT | DocumentIndex | |
| Mar 20, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Mar 17, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Mar 13, 2026 | S-3 | Shelf registration | DocumentIndex |
| Mar 12, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Mar 12, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 12, 2026 | 8-K | Material event | DocumentIndex |
| Mar 11, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Mar 9, 2026 | 8-K | Material event | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 13, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Feb 5, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jan 30, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jan 27, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Jan 27, 2026 | 8-K | Material event | DocumentIndex |
| Jan 15, 2026 | 8-K | Material event | DocumentIndex |
| Jan 5, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |